Company Overview of Kiadis Pharma B.V.
Kiadis Pharma B.V., a clinical stage biopharmaceutical company, develops life-saving therapies for blood cancer patients in the United States and Europe. The company focuses on the development of a cellular therapeutic that enables partially mismatched donor stem cell transplants from family members in blood cancer patients. It offers ATIR, a cell-based medicinal product that facilitates early immune system recovery without causing life-threatening graft-versus-host-disease when administered as an adjunctive to a haploidentical stem cell transplantation. Kiadis Pharma B.V. was formerly known as Kiadis B.V. and changed its name to Kiadis Pharma B.V. in 2006. The company was founded in 1997 an...
Amsterdam, 1114 AA
Founded in 1997
Key Executives for Kiadis Pharma B.V.
Chief Development Officer and Senior Vice President
Corporate Secretary and General Counsel
Compensation as of Fiscal Year 2014.
Kiadis Pharma B.V. Key Developments
Kiadis Pharma B.V. Presents at BioEquity Europe 2014, May-22-2014 03:20 PM
Mar 14 14
Kiadis Pharma B.V. Presents at BioEquity Europe 2014, May-22-2014 03:20 PM. Venue: Hilton Amsterdam Hotel, Amsterdam, Netherlands.
Kiadis Pharma B.V. Presents at 8th Annual BIO Europe Spring 2014, Mar-11-2014 11:30 AM
Jan 21 14
Kiadis Pharma B.V. Presents at 8th Annual BIO Europe Spring 2014, Mar-11-2014 11:30 AM. Venue: OVAL Lingotto, Turin, Italy.
Kiadis Pharma B.V. Presents at BioCapital Europe 2014, Mar-27-2014 03:00 PM
Jan 10 14
Kiadis Pharma B.V. Presents at BioCapital Europe 2014, Mar-27-2014 03:00 PM. Venue: Sofitel Amsterdam The Grand, Oudezijds Voorburgwal 197, 1012 EX Amsterdam, Netherlands.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries